Related Experiment Videos
[Ocular impairment during type II membranoproliferative glomerulonephritis]
Journal Francais D'Ophtalmologie
|January 8, 2003
Summary
Membranoproliferative glomerulonephritis type II (MPGN) causes dense deposits in the kidneys and eyes. This condition can lead to vision loss through retinal lesions and central serous retinopathy.
Area of Science:
- Nephrology
- Ophthalmology
- Pathology
Background:
- Membranoproliferative glomerulonephritis type II (MPGN) is a rare kidney disease.
- Characterized by electron-dense deposits in glomerular basal membranes.
- These deposits can also affect Bruch's membrane in the eye, mimicking drusen.
Observation:
- A 50-year-old patient with chronic renal deficiency presented with central bilateral serous retinopathy.
- Ophthalmoscopic and angiographic findings were consistent with MPGN type II.
- Diffuse punctiform yellow subretinal lesions were noted.
Findings:
- MPGN type II involves dense deposits in the glomerular basal membrane and Bruch's membrane.
- Ocular manifestations include central serous chorioretinopathy and choroidal neovascularization.
- The disease impacts both renal and ocular structures.
Implications:
- Highlights the link between renal pathology and specific retinal lesions.
- Emphasizes the importance of ophthalmologic evaluation in MPGN type II diagnosis.
- Provides insight into the clinical and evolutionary aspects of MPGN type II ocular complications.